Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Item
http://www.wikidata.org/entity/Q36295053
Indium-111-octreotide scintigraphy, intraoperative gamma-detector localisation and somatostatin receptor expression in primary human breast cancer.Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer.Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study.Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumoursA review of the use of somatostatin analogs in oncologyPhase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.Current treatment options for hyperprolactinemia.[Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: a possibility for secondary hormonal ablation?].Lysozyme expression by breast carcinomas, correlation with clinicopathologic parameters, and prognostic significance.Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
P2860

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up.

Item
http://www.wikidata.org/entity/Q36295053
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@ast
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@en
type
label
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@ast
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@en
prefLabel
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@ast
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Feasibility, endocrine and ant ...... tudy with long-term follow-up.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932